Upregulation of galectin-3 in relation to the severity of cardiomyopathy due to transgenic beta-adrenergic activation
27 August 2016 (00:00 - 00:00)
Organised by:
About the speaker

Baker Heart and Diabetes Institute, Melbourne (Australia)
15 More presentations in this session
Ms A. Di Bona (Padova, IT)
Doctor P. Niewinski (Wroclaw, PL)
Doctor T. Zaglia (Padova, IT)
Access the full session
The Event
ESC Congress 2016
27 August - 31 August 2016
